Report Detail

Request for Sample of this report

Pharma & Healthcare Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025

  • RnM3784496
    • |
  • 26 September, 2019
    • |
  • Global
    • |
  • 91 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL

Market segment by Type, the product can be split into
Human iPSCs
Mouse iPSCs

Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.

Market segment by Application, split into
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine

Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2018.

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players.
To present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells (iPSCs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Human iPSCs
      • 1.4.3 Mouse iPSCs
    • 1.5 Market by Application
      • 1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
      • 1.5.2 Academic Research
      • 1.5.3 Drug Development and Discovery
      • 1.5.4 Toxicity Screening
      • 1.5.5 Regenerative Medicine
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size
    • 2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
      • 2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2025)
      • 2.2.2 Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by by Players
      • 3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by by Players (2014-2019)
      • 3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
    • 3.3 Key Players Induced Pluripotent Stem Cells (iPSCs) Product/Solution/Service
    • 3.4 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2014-2019)
    • 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 5.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America
    • 5.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 5.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    6 Europe

    • 6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe
    • 6.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 6.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    7 China

    • 7.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China
    • 7.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 7.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    8 Japan

    • 8.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan
    • 8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 8.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia
    • 9.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 9.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    10 India

    • 10.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India
    • 10.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 10.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America
    • 11.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 11.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    12 International Players Profiles

    • 12.1 Fujifilm Holding Corporation (CDI)
      • 12.1.1 Fujifilm Holding Corporation (CDI) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019))
      • 12.1.5 Fujifilm Holding Corporation (CDI) Recent Development
    • 12.2 Ncardia
      • 12.2.1 Ncardia Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.2.5 Ncardia Recent Development
    • 12.3 Sumitomo Dainippon Pharma
      • 12.3.1 Sumitomo Dainippon Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.3.5 Sumitomo Dainippon Pharma Recent Development
    • 12.4 Astellas Pharma Inc
      • 12.4.1 Astellas Pharma Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.4.5 Astellas Pharma Inc Recent Development
    • 12.5 Fate Therapeutics, Inc
      • 12.5.1 Fate Therapeutics, Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.5.5 Fate Therapeutics, Inc Recent Development
    • 12.6 Pluricell Biotech
      • 12.6.1 Pluricell Biotech Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.6.5 Pluricell Biotech Recent Development
    • 12.7 Cell Inspire Biotechnology
      • 12.7.1 Cell Inspire Biotechnology Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.7.5 Cell Inspire Biotechnology Recent Development
    • 12.8 ReproCELL
      • 12.8.1 ReproCELL Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.8.5 ReproCELL Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Induced Pluripotent Stem Cells (iPSCs). Industry analysis & Market Report on Induced Pluripotent Stem Cells (iPSCs) is a syndicated market report, published as Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Induced Pluripotent Stem Cells (iPSCs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,900.00
      		$5,850.00
      		$7,800.00
      		3,065.40
      		4,598.10
      		6,130.80
      		3,685.50
      		5,528.25
      		7,371.00
      		605,280.00
      		907,920.00
      		1,210,560.00
      		329,316.00
      		493,974.00
      		658,632.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo